Acro Biomedical Co. Ltd. (ACBM)
0.026
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Acro Biomedical Debt to Equity Ratio : -0.8665 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8665 |
| March 31, 2026 | -0.878 |
| December 31, 2025 | -0.8411 |
| September 30, 2025 | -0.6944 |
| June 30, 2025 | -0.8041 |
| March 31, 2025 | -0.5459 |
| December 31, 2024 | -0.5169 |
| September 30, 2024 | -0.5208 |
| June 30, 2024 | -0.5387 |
| March 31, 2024 | -0.5455 |
| December 31, 2023 | -0.5486 |
| September 30, 2023 | -0.3573 |
| June 30, 2023 | 0.2708 |
| March 31, 2023 | 0.239 |
| December 31, 2022 | 0.2148 |
| September 30, 2022 | 0.2247 |
| June 30, 2022 | 0.1033 |
| March 31, 2022 | 0.1017 |
| December 31, 2021 | 0.1106 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.0449 |
| June 30, 2021 | 0.0439 |
| March 31, 2021 | 0.4387 |
| December 31, 2020 | 0.39 |
| September 30, 2020 | 0.2932 |
| June 30, 2020 | 0.1961 |
| March 31, 2020 | 0.1189 |
| December 31, 2019 | 0.091 |
| September 30, 2019 | 0.0707 |
| June 30, 2019 | 0.1091 |
| March 31, 2019 | 0.0184 |
| September 30, 2018 | 0.1136 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Exlites Holdings International, Inc. | 0.00 |
| Xcelerate, Inc. | -0.8535 |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Vivos Therapeutics, Inc. | -3.278 |
| Stella Diagnostics, Inc. | -0.4877 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.0036M |
| Total Liabilities (Quarterly) | 0.4484M |
| Shareholders Equity (Quarterly) | -0.4448M |
| Current Ratio | 0.008 |
| Net Debt Paydown Yield | -2.81% |